COMMUNIQUÉS West-GlobeNewswire

Essilor - News Release: First Quarter Driving Toward Full-Year Targets

27/04/2018 - 06:31

First Quarter Driving Toward Full-Year Targets PDF Version of the news release Sustained momentum in China and return to growth in Brazil Solid trends in mature countries impacted by poor weather Good results in sunwear [...]

Essilor - Communiqué : Premier trimestre en ligne avec l'objectif annuel

27/04/2018 - 06:31

Premier trimestre en ligne avec l'objectif annuel Version PDF du communiqué Dynamique soutenue en Chine et retour à la croissance au Brésil Activité solide dans les pays matures mais conditions climatiques défavorables [...]

MediciNova Announces Additional Data from Completed Clinical Trial of MN-166 (ibudilast) in ALS Presented at the American Academy of Neurology (AAN) 70th Annual Meeting

27/04/2018 - 01:00

LA JOLLA, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875 [...]

Marrone Bio Innovations Announces Exercise of Over-Allotment Option in Public Offering of Common Stock

26/04/2018 - 23:30

DAVIS, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI or the “Company”), a leading provider of bio-based pest management and plant health products for the agriculture, turf [...]

Le Groupe Jean Coutu – Dividende Spécial

26/04/2018 - 23:24

VARENNES, Québec, 26 avr. 2018 (GLOBE NEWSWIRE) -- Le Groupe Jean Coutu (PJC) inc. (la « Société » ou le « Groupe Jean Coutu ») (TSX:PJC.A) annonce que son conseil d’administration a déclaré aujourd’hui un dividende de [...]

The Jean Coutu Group – Special Dividend

26/04/2018 - 23:24

VARENNES, Quebec, April 26, 2018 (GLOBE NEWSWIRE) -- The Jean Coutu Group (PJC) inc. (the "Corporation" or the "Jean Coutu Group") (TSX:PJC.A) announces that its Board of Directors has declared today a dividend of $0. [...]

Integra LifeSciences to Present at Healthcare Conference in May 2018

26/04/2018 - 22:30

PLAINSBORO, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, will present at the following healthcare conferences in May: [...]

AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants

26/04/2018 - 22:30

Bronchiolitis is primarily caused by respiratory syncytial virus (RSV) NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB), a clinical-stage medical device and biopharmaceutical company [...]

Adamas to Announce First Quarter 2018 Financial Results and Host Conference Call on May 3, 2018

26/04/2018 - 22:05

EMERYVILLE, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the company will report first quarter 2018 financial results on Thursday, May 3, 2018, after [...]

Vital Therapies Announces Upcoming First Quarter Financial Results Conference Call with Webcast

26/04/2018 - 22:05

SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release [...]

Vical Announces News Release and Conference Call Schedule for First Quarter 2018 Financial Results

26/04/2018 - 22:05

SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) today announced that the company will report financial results for the three months ended March 31, 2018, before the opening of trading on [...]

Chembio Diagnostics to Report First Quarter 2018 Financial Results on May 9, 2018

26/04/2018 - 22:05

MEDFORD, N.Y., April 26, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release financial results for [...]

Akcea Therapeutics Announces Presentations on Volanesorsen and FCS at the National Lipid Association Scientific Sessions

26/04/2018 - 22:05

Results to be presented show significant reduction in triglyceride levels associated with reductions of pancreatitis and burden of disease in patients with FCS CAMBRIDGE, Mass. and LAS VEGAS, April 26, 2018 (GLOBE [...]

TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007

26/04/2018 - 22:01

REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - April 26, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]

athenahealth Reports First Quarter Fiscal Year 2018 Results

26/04/2018 - 22:01

Company Achieves Double Digit Revenue Growth and Increases Operating Margin; Reaffirms Fiscal Year 2018 Financial Outlook WATERTOWN, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ) (“ [...]

Trevena to Report First Quarter 2018 Financial Results on May 3, 2018

26/04/2018 - 22:01

CHESTERBROOK, Pa., April 26, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will host a conference call and webcast on Thursday, May 3, 2018 at 8:00 am EDT to review financial results for [...]

Editas Medicine to Host Conference Call Discussing First Quarter 2018 Corporate Update and Results

26/04/2018 - 22:01

CAMBRIDGE, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced that it will host a conference call and webcast on Thursday, May 3, 2018, at [...]

Cytokinetics, Inc. Reports First Quarter 2018 Financial Results

26/04/2018 - 22:00

Completed Enrollment in Phase 2 Study of Reldesemtiv in Patients with SMA; Data Expected in Q2 2018 Preparing to Initiate Second Phase 3 Clinical Trial of Omecamtiv Mecarbil SOUTH SAN FRANCISCO, Calif., April 26, 2018 ( [...]

Cambrex to Announce First Quarter 2018 Financial Results on May 3, 2018

26/04/2018 - 21:15

EAST RUTHERFORD, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]